A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
Bixlenvo offers a simplified option for patients whose HIV is under control but who can’t use current single-pill treatments.
August 31 2026 2:31 PM
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Bixlenvo offers a simplified option for patients whose HIV is under control but who can’t use current single-pill treatments.
The once-daily regimen for those with HIV can now be prescribed to those with a common treatment resistance.
Ninety percent of study participants preferred the every-two-month HIV treatment regimen over taking a daily pill.